GLP-1 drugs for weight loss linked to vision loss
Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label about a possible link…
Attributed summary
Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label about a possible link to permanent vision loss, the US Food and Drug Administration has said. Older age people, those suffering with diabetes, high blood pressure are at a higher risk. NAION typically causes sudden, painless vision loss, often affecting one eye.
Read the original report — Economic Times
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.
